Skip to main content
Clinical Trials/CTRI/2022/01/039343
CTRI/2022/01/039343Not yet recruiting未知

Prophylactic Phenylephrine and Norepinephrine infusions during Caesarean Delivery for non-reassuring fetal heart rate: A randomised non-inferiority trial to assess neonatal outcome

POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH CHANDIGARH0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. ASA physical status II.
  • 2. Women with category I fetal heart trace at the
  • beginning of labor and later on showed a change
  • to category II trace with/without improvement
  • following intrauterine fetal resuscitation
  • 3. Fetal growth restriction (FGR) requiring
  • emergency CD was included if the subject was
  • near-term pregnancy with fetal biophysical
  • profile more than 6 before induction of labor
  • and later on showed category II trace with
  • normal fetal doppler flows.
  • 4. Women with Category II FHR tracings

Exclusion Criteria

  • 1. Refusal to give informed consent.
  • 2. Age <18yrs.
  • 3. Allergy to phenylephrine and norepinephrine.
  • 4. Contraindication for SA.
  • 5. Known fetal abnormality.
  • 6. Cardiovascular or cerebrovascular diseases.
  • 7. Any autoimmune disorder.
  • 8. Hypertensive disorder of pregnancy.
  • 9. Diabetes mellitus.
  • 10. Multiple gestation.
  • 11. Growth restricted fetus having chronic
  • asphyxia (previous abnormal nonstress test
  • and biophysical profile less than 6).
  • 12. Ruptured membranes with meconium-stained
  • liquor, or evidence of intrauterine infection.

Investigators

Sponsor
POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH CHANDIGARH

Similar Trials